{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T06:10:04Z","timestamp":1789625404529,"version":"build-2803163510"},"reference-count":52,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T00:00:00Z","timestamp":1692576000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>\n                    <jats:bold>Introduction:<\/jats:bold>\n                    Hypoxia-inducible factor (HIF) prolyl hydroxylase domain (PHD) enzymes are major therapeutic targets of anemia and ischemic\/hypoxia diseases. To overcome safety issues, liver failure, and problems associated with on-\/off-targets, natural products due to their novel and unique structures offer promising alternatives as drug targets.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Methods:<\/jats:bold>\n                    In the current study, the Marine Natural Products, North African, South African, East African, and North-East African chemical space was explored for HIF-PHD inhibitors discovery through molecular search, and the final hits were validated using molecular simulation and free energy calculation approaches.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results:<\/jats:bold>\n                    Our results revealed that CMNPD13808 with a docking score of \u22128.690\u00a0kcal\/mol, CID15081178 with a docking score of \u22128.027\u00a0kcal\/mol, CID71496944 with a docking score of \u22128.48\u00a0kcal\/mol and CID11821407 with a docking score of \u22127.78\u00a0kcal\/mol possess stronger activity than the control N-[(4-hydroxy-8-iodoisoquinolin-3-yl)carbonyl]glycine, 4HG (\u22126.87\u00a0kcal\/mol). Interaction analysis revealed that the target compounds interact with Gln239, Tyr310, Tyr329, Arg383 and Trp389 residues, and chelate the active site iron in a bidentate manner in PHD2. Molecular simulation revealed that these target hits robustly block the PHD2 active site by demonstrating stable dynamics. Furthermore, the half-life of the Arg383 hydrogen bond with the target ligands, which is an important factor for PHD2 inhibition, remained almost constant in all the complexes during the simulation. Finally, the total binding free energy of each complex was calculated as CMNPD13808-PHD2 \u221272.91\u00a0kcal\/mol, CID15081178-PHD2 \u221265.55\u00a0kcal\/mol, CID71496944-PHD2 \u221268.47\u00a0kcal\/mol, and CID11821407-PHD2 \u221262.06\u00a0kcal\/mol, respectively.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusion:<\/jats:bold>\n                    The results show the compounds possess good activity in contrast to the control drug (4HG) and need further\n                    <jats:italic>in vitro<\/jats:italic>\n                    and\n                    <jats:italic>in vivo<\/jats:italic>\n                    validation for possible usage as potential drugs against HIF-PHD2-associated diseases.\n                  <\/jats:p>","DOI":"10.3389\/fphar.2023.1202128","type":"journal-article","created":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T10:25:16Z","timestamp":1692613516000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":24,"title":["Exploring the natural products chemical space through a molecular search to discover potential inhibitors that target the hypoxia-inducible factor (HIF) prolyl hydroxylase domain (PHD)"],"prefix":"10.3389","volume":"14","author":[{"given":"Abrar Mohammad","family":"Sayaf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saif","family":"Ullah Khalid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jawad Ahmed","family":"Hameed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulrahman","family":"Alshammari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbas","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anwar","family":"Mohammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeed","family":"Alghamdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Qing","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KarKheng","family":"Yeoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,8,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.procs.2019.08.181","article-title":"Structure of biomolecules through molecular dynamics simulations","volume":"156","author":"Arnittali","year":"2019","journal-title":"Procedia Comput. Sci."},{"key":"B2","doi-asserted-by":"publisher","first-page":"104967","DOI":"10.1016\/j.compbiomed.2021.104967","article-title":"De novo design of novel protease inhibitor candidates in the treatment of SARS-CoV-2 using deep learning, docking, and molecular dynamic simulations","volume":"139","author":"Arshia","year":"2021","journal-title":"Comput. Biol. Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1111\/1440-1681.12717","article-title":"Hypoxia\u2010inducible factors as neuroprotective agent in Alzheimer's disease","volume":"44","author":"Ashok","year":"2017","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1002\/jcc.20290","article-title":"The Amber biomolecular simulation programs","volume":"26","author":"Case","year":"2005","journal-title":"J. Comput. Chem."},{"key":"B5","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1002\/cben.201600027","article-title":"Metal\u2010organic\u2010frameworks as contrast agents in magnetic resonance imaging","volume":"4","author":"Chowdhury","year":"2017","journal-title":"ChemBioEng Rev."},{"key":"B6","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.str.2009.06.002","article-title":"Structural basis for binding of hypoxia-inducible factor to the oxygen-sensing prolyl hydroxylases","volume":"17","author":"Chowdhury","year":"2009","journal-title":"Structure"},{"key":"B7","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1080\/13543784.2018.1417386","article-title":"Roxadustat in the treatment of anaemia in chronic kidney disease","volume":"27","author":"Del Vecchio","year":"2018","journal-title":"Expert Opin. Investig. Drugs"},{"key":"B8","doi-asserted-by":"publisher","first-page":"6349","DOI":"10.1016\/j.bmc.2013.08.046","article-title":"Novel complex crystal structure of prolyl hydroxylase domain-containing protein 2 (PHD2): 2, 8-diazaspiro [4.5] decan-1-ones as potent, orally bioavailable PHD2 inhibitors","volume":"21","author":"Deng","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"B9","doi-asserted-by":"publisher","first-page":"4082","DOI":"10.1093\/emboj\/cdg392","article-title":"HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1alpha in normoxia","volume":"22","author":"Emmanuel","year":"2003","journal-title":"EMBO. J."},{"key":"B10","doi-asserted-by":"publisher","first-page":"10176","DOI":"10.1016\/j.tet.2012.09.097","article-title":"New bioactive alkaloids from the marine sponge Stylissa sp","volume":"68","author":"Fouad","year":"2012","journal-title":"Tetrahedron"},{"key":"B11","doi-asserted-by":"publisher","first-page":"D1417","DOI":"10.1093\/nar\/gkab1013","article-title":"Varidt 2.0: Structural variability of drug transporter","volume":"50","author":"Fu","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1021\/acschemneuro.8b00059","article-title":"Exploring the binding mechanism of metabotropic glutamate receptor 5 negative allosteric modulators in clinical trials by molecular dynamics simulations","volume":"9","author":"Fu","year":"2018","journal-title":"ACS Chem. Neurosci."},{"key":"B13","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.str.2005.01.006","article-title":"Software extensions to UCSF chimera for interactive visualization of large molecular assemblies","volume":"13","author":"Goddard","year":"2005","journal-title":"Structure"},{"key":"B14","doi-asserted-by":"publisher","first-page":"5346","DOI":"10.3390\/ijms21155346","article-title":"Computational studies of SARS-CoV-2 3CLpro: Insights from MD simulations","volume":"21","author":"Grottesi","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B15","doi-asserted-by":"publisher","first-page":"e0216134","DOI":"10.1371\/journal.pone.0216134","article-title":"The conservation and functionality of the oxygen-sensing enzyme Factor Inhibiting HIF (FIH) in non-vertebrates","volume":"14","author":"Hampton-Smith","year":"2019","journal-title":"PLoS One"},{"key":"B16","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/1743-422X-9-217","article-title":"Epitope mapping by random peptide phage display reveals essential residues for vaccinia extracellular enveloped virion spread","volume":"9","author":"He","year":"2012","journal-title":"Virol. J."},{"key":"B17","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1039\/c8md00548f","article-title":"Studies on spiro [4.5] decanone prolyl hydroxylase domain inhibitors","volume":"10","author":"Holt-Martyn","year":"2019","journal-title":"MedChemComm"},{"key":"B18","doi-asserted-by":"publisher","first-page":"104692","DOI":"10.1016\/j.compbiomed.2021.104692","article-title":"Tracking the interaction between single-wall carbon nanotube and SARS-cov-2 spike glycoprotein: A molecular dynamics simulations study","volume":"136","author":"Jomhori","year":"2021","journal-title":"Comput. Biol. Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"6290S","DOI":"10.1158\/1078-0432.CCR-sup-040025","article-title":"The von Hippel-Lindau tumor suppressor gene and kidney cancer","volume":"10","author":"Kaelin","year":"2004","journal-title":"Clin. cancer Res."},{"key":"B20","doi-asserted-by":"publisher","first-page":"159","DOI":"10.3389\/fmolb.2019.00159","article-title":"Dynamics insights into the gain of flexibility by helix-12 in ESR1 as a mechanism of resistance to drugs in breast cancer cell lines","volume":"6","author":"Khan","year":"2020","journal-title":"Front. Mol. Biosci."},{"key":"B21","doi-asserted-by":"publisher","first-page":"7318","DOI":"10.1039\/d2ra00277a","article-title":"Blocking key mutated hotspot residues in the RBD of the omicron variant (B 1.1 529) with medicinal compounds to disrupt the RBD-hACE2 complex using molecular screening and simulation approaches","volume":"12","author":"Khan","year":"","journal-title":"RSC Adv."},{"key":"B22","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.ijbiomac.2022.01.059","article-title":"The Omicron (B 1.1 529) variant of SARS-CoV-2 binds to the hACE2 receptor more strongly and escapes the antibody response: Insights from structural and simulation data","volume":"200","author":"Khan","year":"","journal-title":"Int. J. Biol. Macromol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"7045","DOI":"10.1002\/jcp.30367","article-title":"Higher infectivity of the SARS-CoV-2 new variants is associated with K417N\/T, E484K, and N501Y mutants: An insight from structural data","volume":"236","author":"Khan","year":"2021","journal-title":"J. Cell. Physiology"},{"key":"B24","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1016\/j.kint.2017.03.008","article-title":"Complement C1q is hydroxylated by collagen prolyl 4 hydroxylase and is sensitive to off-target inhibition by prolyl hydroxylase domain inhibitors that stabilize hypoxia-inducible factor","volume":"92","author":"Kiriakidis","year":"2017","journal-title":"Kidney Int."},{"key":"B25","doi-asserted-by":"publisher","first-page":"3658","DOI":"10.1093\/bioinformatics\/btx491","article-title":"FAF-Drugs4: Free ADME-tox filtering computations for chemical biology and early stages drug discovery","volume":"33","author":"Lagorce","year":"2017","journal-title":"Bioinformatics"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2794","DOI":"10.1002\/prot.23106","article-title":"The VSGB 2.0 model: A next generation energy model for high resolution protein structure modeling","volume":"79","author":"Li","year":"2011","journal-title":"Proteins"},{"key":"B27","doi-asserted-by":"publisher","first-page":"D509","DOI":"10.1093\/nar\/gkaa763","article-title":"Cmnpd: A comprehensive marine natural products database towards facilitating drug discovery from the ocean","volume":"49","author":"Lyu","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"B28","volume-title":"Maestro","author":"Maestro","year":"2020"},{"key":"B29","doi-asserted-by":"publisher","first-page":"7680","DOI":"10.1021\/ja050841b","article-title":"Selective inhibition of factor inhibiting hypoxia-inducible factor","volume":"127","author":"McDonough","year":"2005","journal-title":"J. Am. Chem. Soc."},{"key":"B30","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1039\/b509528j","article-title":"Quinoline, quinazoline and acridone alkaloids","volume":"24","author":"Michael","year":"2007","journal-title":"Nat. Product. Rep."},{"key":"B31","doi-asserted-by":"publisher","first-page":"e78085","DOI":"10.1371\/journal.pone.0078085","article-title":"AfroDb: A select highly potent and diverse natural product library from african medicinal plants","volume":"8","author":"Ntie-Kang","year":"2013","journal-title":"PLOS ONE"},{"key":"B32","doi-asserted-by":"publisher","first-page":"528","DOI":"10.14348\/molcells.2015.0026","article-title":"The Histone Methyltransferase Inhibitor BIX01294 Inhibits HIF-1\u03b1 Stability and Angiogenesis","volume":"38","author":"Oh","year":"2015","journal-title":"Mol. Cells"},{"key":"B33","doi-asserted-by":"publisher","first-page":"2945","DOI":"10.1016\/j.bmcl.2014.04.060","article-title":"\u03b2-Secretase (BACE1)-inhibiting C-methylrotenoids from Abronia nana suspension cultures","volume":"24","author":"Park","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/j.kint.2016.07.019","article-title":"Vadadustat, a novel oral HIF stabilizer, provides effective anemia treatment in nondialysis-dependent chronic kidney disease","volume":"90","author":"Pergola","year":"2016","journal-title":"Kidney Int."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF chimera\u2014A visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J. Comput. Chem."},{"key":"B36","doi-asserted-by":"publisher","first-page":"10096","DOI":"10.1063\/1.1808117","article-title":"A modified TIP3P water potential for simulation with Ewald summation","volume":"121","author":"Price","year":"2004","journal-title":"J. Chem. Phys."},{"key":"B37","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1021\/np020592u","article-title":"New manzamine alkaloids with activity against infectious and tropical parasitic diseases from an Indonesian sponge","volume":"66","author":"Rao","year":"2003","journal-title":"J. Nat. Prod."},{"key":"B38","doi-asserted-by":"publisher","first-page":"e1004586","DOI":"10.1371\/journal.pcbi.1004586","article-title":"AutoDockFR: Advances in protein-ligand docking with explicitly specified binding site flexibility","volume":"11","author":"Ravindranath","year":"2015","journal-title":"PLoS Comput. Biol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"3084","DOI":"10.1021\/ct400341p","article-title":"PTRAJ and CPPTRAJ: Software for processing and analysis of molecular dynamics trajectory data","volume":"9","author":"Roe","year":"2013","journal-title":"J. Chem. theory Comput."},{"key":"B40","doi-asserted-by":"publisher","first-page":"D345","DOI":"10.1093\/nar\/gku1214","article-title":"The RCSB protein Data Bank: Views of structural biology for basic and applied research and education","volume":"43","author":"Rose","year":"2016","journal-title":"Nucleic acids Res."},{"key":"B41","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1021\/ml100198y","article-title":"Benzimidazole-2-pyrazole HIF prolyl 4-hydroxylase inhibitors as oral erythropoietin secretagogues","volume":"1","author":"Rosen","year":"2010","journal-title":"ACS Med. Chem. Lett."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1021\/acs.jctc.7b00028","article-title":"How molecular size impacts RMSD applications in molecular dynamics simulations","volume":"13","author":"Sargsyan","year":"2017","journal-title":"J. Chem. Theory Comput."},{"key":"B43","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1146\/annurev-pathol-012513-104720","article-title":"Oxygen sensing, hypoxia-inducible factors, and disease pathophysiology","volume":"9","author":"Semenza","year":"2014","journal-title":"Annu. Rev. Pathology Mech. Dis."},{"key":"B44","doi-asserted-by":"publisher","first-page":"8828","DOI":"10.1523\/JNEUROSCI.1779-09.2009","article-title":"Selective inhibition of hypoxia-inducible factor (HIF) prolyl-hydroxylase 1 mediates neuroprotection against normoxic oxidative death via HIF- and CREB-independent pathways","volume":"29","author":"Siddiq","year":"2009","journal-title":"J. Neurosci."},{"key":"B45","doi-asserted-by":"publisher","first-page":"16719","DOI":"10.1039\/c4cp01388c","article-title":"Assessing the performance of MM\/PBSA and MM\/GBSA methods. 4. Accuracies of MM\/PBSA and MM\/GBSA methodologies evaluated by various simulation protocols using PDBbind data set","volume":"16","author":"Sun","year":"2014","journal-title":"Phys. Chem. Chem. Phys."},{"key":"B46","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1080\/07391102.2020.1714480","article-title":"In silico identification of hydantoin derivatives: A novel natural prolyl hydroxylase inhibitor","volume":"39","author":"Teli","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"key":"B47","doi-asserted-by":"publisher","first-page":"3891","DOI":"10.1016\/j.bmc.2017.05.026","article-title":"Application of in-vitro screening methods on hypoxia inducible factor prolyl hydroxylase inhibitors","volume":"25","author":"Wu","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1039\/c6md00240d","article-title":"Small-molecule inhibitors of HIF-PHD2: A valid strategy to renal anemia treatment in clinical therapy","volume":"7","author":"Wu","year":"2016","journal-title":"Medchemcomm"},{"key":"B49","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1021\/acschemneuro.1c00694","article-title":"Molecular mechanism for the allosteric inhibition of the human serotonin transporter by antidepressant escitalopram","volume":"13","author":"Xue","year":"2022","journal-title":"ACS Chem. Neurosci."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1021\/acschemneuro.7b00490","article-title":"What contributes to serotonin-norepinephrine reuptake inhibitors' dual-targeting mechanism? The key role of transmembrane domain 6 in human serotonin and norepinephrine transporters revealed by molecular dynamics simulation","volume":"9","author":"Xue","year":"2018","journal-title":"ACS Chem. Neurosci."},{"key":"B51","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S1875-5364(19)30008-1","article-title":"Anti-cancer activities of S-allylmercaptocysteine from aged garlic","volume":"17","author":"Yi","year":"2019","journal-title":"Chin. J. Nat. Med."},{"key":"B52","doi-asserted-by":"publisher","first-page":"e1298","DOI":"10.1002\/wcms.1298","article-title":"Using PyMOL as a platform for computational drug design","volume":"7","author":"Yuan","year":"2017","journal-title":"Wiley Interdiscip. Rev. Comput. Mol. Sci."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1202128\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T10:25:19Z","timestamp":1692613519000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1202128\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,21]]},"references-count":52,"alternative-id":["10.3389\/fphar.2023.1202128"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2023.1202128","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,21]]},"article-number":"1202128"}}